Skip to main content
Premium Trial:

Request an Annual Quote

Managing HIV in Africa

Researchers from Massachusetts General Hospital and Harvard Medical School have developed a microfluidic device that can be used as an alternative to flow cytometry for measuring T cell counts in people infected with HIV. They hope that the small handheld device will help Africans — it will first be tested in Rwanda — in poor regions to better manage their disease. The device consists of a chip lined with a channel, on which are spotted molecules that bind to CD4, a protein found on T cells; a simple light microscope then counts the cells.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.